Unum Therapeutics Inc. | 200 Cambridge Park Drive Suite 3100 | Cambridge, MA 02140  USA

Tel. +1.617.945.5576 | Email: info@unumrx.com

  • LinkedIn - White Circle
  • Twitter - White Circle

© Copyright 2014-2019 Unum Therapeutics

December 01, 2016

Unum Therapeutics to Present at 58th American Society of Hematology (ASH) Annual Meeting

Unum Therapeutics has been selected for two poster presentations on its Antibody-Coupled T-cell Receptor (ACTR) platform at the 58th ASH Annual Meeting.

November 29, 2016

Unum Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference

Unum Therapeutics, announced that President and Chief Executive Officer Chuck Wilson will present at the 28th Annual Piper Jaffray Healthcare Conference on November 30, 2016 at 11:30 am ET.

October 20, 2016

Unum Therapeutics to Present on its Antibody-Coupled T-Cell Receptor (ACTR) Platform at the American Association for Cancer Research (AACR) Tumor Immunology and Immunotherapy 2016 Meeting

Unum Therapeutics, has been selected for two poster presentations on its Antibody-Coupled T-Cell Receptor (ACTR) platform at the American Association for Cancer Research (AACR) Tumor Immunology and Immunotherapy 2016 Meeting.

September 21, 2016

Unum Therapeutics to Present at the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology

Unum Therapeutics, announced that President and Chief Executive Officer Chuck Wilson will present at the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology on September 29, 2016 at 12:30 pm ET.

August 08, 2016

Unum Therapeutics to Present at 2016 Wedbush PacGrow Healthcare Conference

Unum Therapeutics President and Chief Executive Officer Chuck Wilson will present at the Wedbush PacGrow Healthcare Conference on August 17, 2016 at 1:20 pm ET. The conference is being held August 16-17, 2016 at the Le Parker Meridien in New York.

June 19, 2016

Unum Therapeutics Announces Active Investigational New Drug (IND)

Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR087 in Patients with Relapsed/Refractory B-cell Lymphoma

March 02, 2016

Unum Therapeutics to Present at 36th Annual Health Care Conference

Unum Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference

February 09, 2016

Unum Therapeutics Appoints Jörn Aldag

Unum Therapeutics Appoints Jörn Aldag, an Acclaimed Biotechnology Veteran and Gene Therapy Pioneer, to its Board of Directors

February 02, 2016

New Scientific Advisory Board

Unum Therapeutics Appoints Internationally Renowned Cancer Immunotherapy Experts to Newly Formed Scientific Advisory Board

January 26, 2016

New Headquarters

Unum Therapeutics Moves to New Headquarters in Cambridge, MA as It Continues to Expand and Advance its Cellular Immunotherapy Pipeline

Please reload